Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Folks if you do not have plans to buy more shares yur

<< Previous

Bullboard Posts

Next >>

Comment by Captainblkon Feb 11, 2021 7:36pm

166 Views

Post# 32548129

RE:Folks if you do not have plans to buy more shares yur

Dude51 wrote: going to be pissssed. Alice here we come. We made the right move on this one folks mark my words; Dude51 says this is one hell of an investment, patients is key.

Okay Robert you have my permission as a shareholder, you have my permission to buy out this small start up company. I really must insist that we get with these folks el pronto.
I do not see a down side and I know you like to buy companies, 3rd time a charm? Talk with Mr. Salzman, get working on this acquisition, you want to see a stock go ballistic? Do it, you can do it....
Even if we do not buy this start up company the fact were developing along the same line is huge.

https://omny.fm/shows/charles-adler-tonight/a-canadian-company-s-promising-solution-to-the-cov

This is rather Pumpy. one companies success =/= ours. for all we know they could be shuttering KLY all together leaving us high and dry
GLTA